Oncology & Cancer
New drug hope for babies with leukaemia
Telethon Kids Institute (TKI) researchers have discovered a new drug combination to help babies battle a rare, aggressive type of leukaemia with grim cure rates.
Oct 12, 2016
0
0
Leukaemia
Medications
Ibrutinib in CLL: Added benefit for treatment-naive patients not proven
Ibrutinib was approved in 2014 for the treatment of certain adults with chronic lymphocytic leukaemia (CLL), particularly as second-line treatment. The therapeutic indication was expanded in 2016. The drug is now also approved ...
Oct 11, 2016
0
0
Oncology & Cancer
Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia
Researchers at Newcastle University have been able to accurately predict how children whose cancer returns after treatment for leukaemia are likely to respond to further treatment.
Aug 18, 2016
0
1
Oncology & Cancer
Leukaemia blood testing has 'massive potential'
Researchers at The University of Manchester have unlocked the potential of a new test which could revolutionise the way doctors diagnose and monitor a common childhood Leukaemia.
Aug 17, 2016
0
0
Oncology & Cancer
New insights into blood cancer that develops before birth
Researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh have identified the cells responsible for a form of leukaemia that can develop while a baby is in the womb. ...
Jul 8, 2016
0
5
Medications
Idelalisib in second-line treatment for CLL: Added benefit again not proven
Already in 2014, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with ...
Jul 6, 2016
0
0
Oncology & Cancer
New types of blood cancer discovered in children
Through a detailed study of leukaemia cells from more than 200 children, a research group at Lund University in Sweden has discovered two new types of childhood leukaemia. Using next-generation sequencing technology (NGS), ...
Jun 7, 2016
0
3
Medications
Ibrutinib: Indication of added benefit in one of three therapeutic indications
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since ...
May 2, 2016
0
2
Oncology & Cancer
Scientists identify possible double drug combination to attack leukaemia
Manchester scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia, according to a study published in the journal Cell Death and Disease today.
Apr 8, 2016
0
14
Oncology & Cancer
New treatment for chronic lymphatic leukaemia could replace chemotherapy
Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly ...
Mar 16, 2016
0
2
